Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial.

Javaud N, Soria A, Maignan M, Martin L, Descamps V, Fain O, Bouillet L, Berard F, Tazarourte K, Roy PM, Fontaine JP, Bagot M, Khellaf M, Goulet H, Lapostolle F, Casalino E, Doutre MS, Gil-Jardine C, Caux F, Chosidow O, Pateron D, Vicaut E, Adnet F.

BMJ Open. 2019 Aug 21;9(8):e027431. doi: 10.1136/bmjopen-2018-027431.

2.

Immediate Hypersensitivity to Contrast Agents: The French 5-year CIRTACI Study.

Clement O, Dewachter P, Mouton-Faivre C, Nevoret C, Guilloux L, Bloch Morot E, Katsahian S, Laroche D; investigators of the CIRTACI study, Audebert M, Benabes-Jezraoui B, Benoit Y, Beot S, Berard F, Berthezene Y, Bertrand P, Bouffard J, Bourrain JL, Boyer B, Carette MF, Caron-Poitreau C, Cavestri B, Cercueil JP, Charpin DA, Collet E, Crombe-Ternamian A, Dalmas J, Decoux E, Defrance MF, Delaval Y, Demoly P, Depriester C, Depriester P, Didier A, Drouet M, Dupas B, Dupre-Goetchebeur D, Dzviga C, Fabre C, Ferretti G, Fourre-Jullian C, Girardin P, Giron J, Gouitaa M, Grenier N, Guenard Bilbault L, Guez S, Gunera-Saad N, Heautot JF, Herbin D, Hoarau C, Jacquot C, Julien C, Laborie L, Lambert C, Larroche P, Leclerc X, Lemaitre L, Leynadier F, Lillo-Le-Louet A, Louvel JP, Louvier N, Lucas MM, Meites G, Mennesson N, Metge L, Meunier Y, Monnier-Cholley L, Musacchio M, Nicolie B, Occelli G, Oesterle H, Paisant-Thouveny F, Panuel M, Railhac N, Rety-Jacob F, Rochefort-Morel C, Roy C, Sarlieve P, Sesay M, Sgro C, Taourel P, Terrier P, Theissen O, Topenot I, Valfrey J, Veillon F, Vergnaud MC, Veyret C, Vincent D, Wallaert B, Wessel F, Zins M.

EClinicalMedicine. 2018 Jul 28;1:51-61. doi: 10.1016/j.eclinm.2018.07.002. eCollection 2018 Jul.

3.

The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).

Lacour JP, Khemis A, Giordano-Labadie F, Martin L, Staumont-Salle D, Hacard F, Tian H, McBride D, Hollis K, Hunter S, Martin L, Lamirand A, Le Guen S, Balp MM, Berard F.

Eur J Dermatol. 2018 Dec 1;28(6):795-802. doi: 10.1684/ejd.2018.3446.

PMID:
30698148
4.

[NSAID urticaria: Similar management to acute urticaria].

Khandzian M, Hacard F, Braire-Bourrel M, Jaulent C, Bérard F, Nicolas JF, Nosbaum A.

Rev Med Interne. 2019 Mar;40(3):166-172. doi: 10.1016/j.revmed.2018.12.008. Epub 2019 Jan 7. French.

PMID:
30630637
5.

Long-lasting allergic contact dermatitis to methylisothiazolinone misdiagnosed as atopic dermatitis.

Deschamps T, Nosbaum A, Delcroix F, Vocanson M, Berard F, Nicolas JF.

Eur J Dermatol. 2019 Feb 1;29(1):100-101. doi: 10.1684/ejd.2018.3456. No abstract available.

PMID:
30530423
6.

Therapeutic patient education improves knowledge and skills for patients with chronic spontaneous urticaria.

Hacard F, Martin C, Verdu V, Montagnon A, Augey F, Braire-Bourrel M, Nicolas JF, Berard F, Nosbaum A.

Eur J Dermatol. 2018 Dec 1;28(6):823-827. doi: 10.1684/ejd.2018.3442.

PMID:
30530411
7.

Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.

Siebert M, Alyami M, Mercier F, Gallice C, Villeneuve L, Bérard F, Glehen O, Bakrin N, Kepenekian V.

Cancer Chemother Pharmacol. 2019 Mar;83(3):425-430. doi: 10.1007/s00280-018-3740-3. Epub 2018 Dec 3.

PMID:
30511218
8.

Adaptation to visual feedback delays on touchscreens with hand vision.

Cattan E, Perrier P, Bérard F, Gerber S, Rochet-Capellan A.

Exp Brain Res. 2018 Dec;236(12):3191-3201. doi: 10.1007/s00221-018-5368-2. Epub 2018 Sep 6.

PMID:
30191261
9.

Efficacy and Safety of Infliximab Tolerance Induction in Patients with Inflammatory Bowel Diseases who Experienced Acute Infusion Reactions.

Pauchard I, Nancey S, Hacard F, Williet N, Roblin X, Moussata D, Bérard F, Flourié B, Boschetti G.

Dig Dis. 2018;36(6):417-426. doi: 10.1159/000491078. Epub 2018 Aug 21.

PMID:
30130790
10.

Epidermolysis bullosa simplex generalized severe induces a T helper 17 response and is improved by apremilast treatment.

Castela E, Tulic MK, Rozières A, Bourrat E, Nicolas JF, Kanitakis J, Vabres P, Bessis D, Mazereeuw J, Morice-Picard F, Baty D, Berard F, Lacour JP, Passeron T, Chiaverini C.

Br J Dermatol. 2019 Feb;180(2):357-364. doi: 10.1111/bjd.16897. Epub 2018 Dec 2.

PMID:
29932457
11.

Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.

Bérard F, Ferrier Le Bouedec MC, Bouillet L, Reguiai Z, Barbaud A, Cambazard F, Milpied B, Pelvet B, Kasujee I, Gharbi H, Lacour JP.

Br J Dermatol. 2019 Jan;180(1):56-66. doi: 10.1111/bjd.16904. Epub 2018 Sep 17.

PMID:
29927483
12.

Tolerance of methotrexate in a daily practice cohort of adults with atopic dermatitis.

Delcasso B, Goujon C, Hacard F, Delcroix F, Grande S, Berard F, Nicolas JF, Nosbaum A.

Eur J Dermatol. 2018 Apr 1;28(2):266-267. doi: 10.1684/ejd.2018.3231. No abstract available.

PMID:
29624179
13.

Economic and organizational impact of the changing hospital funding practices of erythropoiesis-stimulating agents on the management of care of dialysis patients in France.

Therasse C, Fusier I, Cordonnier AL, Bérard F, de Curzon OP, Bocquet F, Paubel P.

J Comp Eff Res. 2018 Jun;7(6):569-580. doi: 10.2217/cer-2017-0067. Epub 2018 Mar 14.

14.

Occupational immediate contact allergy to hydrolysed wheat protein after cosmetic exposure.

Delaunay J, Hacard F, Denery-Papini S, Garnier L, Bérard F, Nicolas JF, Nosbaum A.

Contact Dermatitis. 2018 Apr;78(4):291-292. doi: 10.1111/cod.12929. No abstract available.

PMID:
29527727
15.

Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.

Perino E, Freymond N, Devouassoux G, Nicolas JF, Berard F.

Ann Allergy Asthma Immunol. 2018 Jun;120(6):664-666. doi: 10.1016/j.anai.2018.02.018. Epub 2018 Feb 23. No abstract available.

PMID:
29481891
16.

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU.

Sussman G, Abuzakouk M, Bérard F, Canonica W, Oude Elberink H, Giménez-Arnau A, Grattan C, Hollis K, Hunter S, Knulst A, Lacour JP, Lynde C, Marsland A, McBride D, Maurer M, Nakonechna A, Ortiz de Frutos J, Reynolds M, Sweeney C, Tian H, Weller K, Wolin D, Balp MM.

Allergy. 2018 Aug;73(8):1724-1734. doi: 10.1111/all.13430.

17.

A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay.

Viel S, Pescarmona R, Belot A, Nosbaum A, Lombard C, Walzer T, Bérard F.

Front Immunol. 2018 Jan 29;9:110. doi: 10.3389/fimmu.2018.00110. eCollection 2018.

18.

Methotrexate does not impede the development of contact allergy.

Yfanti I, Nosbaum A, Berard F, Nicolas JF.

Contact Dermatitis. 2018 Mar;78(3):223-224. doi: 10.1111/cod.12901. No abstract available.

PMID:
29430711
19.

Wells' syndrome-like reaction following Argas reflexus bites.

Martin C, Debarbieux S, Rozieres A, Hilger C, Berard F.

Eur J Dermatol. 2018 Apr 1;28(2):253-254. doi: 10.1684/ejd.2018.3217. No abstract available.

PMID:
29400289
20.

Drug-induced aseptic meningitis: A possible T-cell-mediated hypersensitivity.

Castagna J, Nosbaum A, Vial T, Rozieres A, Hacard F, Vocanson M, Pralong P, Chuniaud-Louche C, Nicolas JF, Gouraud A, Bérard F.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1409-1411. doi: 10.1016/j.jaip.2017.11.034. Epub 2018 Jan 6. No abstract available.

PMID:
29310902

Supplemental Content

Loading ...
Support Center